Q. | What is the selection and review process? |
A. | Following the submission of a proposal, TPI will evaluate all non-confidential information,
involving either Pfizer internal or external experts as appropriate. If necessary, one or more meetings with the Company
could be held. If TPI decides to proceed with further due diligence, a one-way confidentiality and disclosure agreement (CDA)
will be signed. This will allow a more in depth review of the company proposal and intellectual property.
After signing the CDA, no further information is shared with Pfizer scientists. Finally, the proposals selected
for investment have to be approved by the TPI Board. |
| |
Q. | Why should I consider building my company with TPI as opposed to more traditional investors like venture capitalists or angel investors? |
A. | We advise entrepreneurs to explore all available funding options.
TPI can be a good fit for companies developing early technology or product concepts that could potentially be transformational.
Because TPI is interested in technologies and products themselves rather than focusing solely on financial return, we
would consider companies and/or ventures with earlier technologies and higher risk profiles. |
| |
Q. | Will TPI incubate pre-existing early stage companies? |
A. | Yes, TPI is interested in investing in companies at various stages,
including pre-series A companies. Depending on the scientific confidence in rationale of a proposal,
funding may be provided in defined stages, contingent on key experiments, before full funding is granted. |
Q. | What is the size of investment that the Pfizer Incubator will make? |
A. | Although there is no pre-determined investment size, TPI plans to invest on
average about $2 million dollars a year in each incubated company and funding will typically be granted for two years. |
| |
Q. | Is The Pfizer Incubator just located in La Jolla, CA? |
A. | No, there are no geographical constraints. TPI will consider companies
across the US and even internationally |
| |
Q. | Can funding continue beyond two years? |
A. | Yes, on a case-by-case basis, TPI could consider funding an incubated
company beyond two years if justified by the status of its research program. |
| |
Q. | What other support infrastructure will incubated companies have access to?
Will companies have access to any Pfizer resources such as their chemical libraries for screening? |
A. | TPI will provide laboratory space that can accommodate both chemistry
and biology projects. TPI will also provide basic laboratory equipment and scientific services such as IT support,
glass wash services and waste collection and disposal. Dependant on the project or technology, companies may also
have access to other Pfizer services such as the ability to screen the Pfizer chemical library. Access to other
equipment and services such as NMR instrumentation and ADME profiling may also be available on a case by case basis. |
| |
Home
Contact
FAQ
